Shaun Marcum ruled out through the All-Star break

5 Comments

The last time we checked in on Shaun Marcum, he was still experiencing some soreness in his throwing elbow while playing catch. Things haven’t improved over the past few days.

Brewers manager Ron Roenicke told Todd Rosiak of the Milwaukee Journal Sentinel this afternoon that Marcum will be sidelined through the All-Star break. The 30-year-old right-hander has been playing catch on a daily basis to gauge his progress, but the team simply hasn’t seen enough improvement in his symptoms.

“Threw again today; still felt it,” Roenicke said. “A little better, but still felt it. I don’t think he’ll make a start before the all-star break. I don’t think there’s any way we can do that.

“But hopefully we get him to where he’s confident that he can go out there and throw the ball and not feel anything. That’s where we’re trying to get to.”

Marcum previously underwent Tommy John surgery back in 2008 and missed the entire 2009 season, but two MRIs have ruled out any new damage to the ulnar collateral ligament in his elbow. For now, the Brewers will just have to hope that the soreness subsides with rest.

Marcum, who is due to become a free agent this winter, has a 3.39 ERA and 77/26 K/BB ratio in 82 1/3 innings across 13 starts this season. Marco Estrada and rookie Michael Fiers will continue to get starts during his absence.

Mets sign Matt Kemp to minor league deal

Matt Kemp
Getty Images
2 Comments

The Mets have had a lot of injuries in their outfield. How many? So many that they’re bringing in Matt Kemp, who they just signed on a minor league deal. Hey, why not? He’s functionally free.

Kemp was released by the Reds earlier this month after batting just .200/.210/.283 over 62 plate appearances. While he was a pretty useful player for the first half of the 2018 season for the Dodgers, the odds of him making major contributions to the Mets this year are probably about the same odds there were on Adrián González making an impact when the Mets signed him last year. But again: what’s the harm?